Sleep Medicine
Volume 10, Issue 6 , Pages 661-663 , June 2009

Weight loss in narcolepsy patients treated with sodium oxybate

  • Aatif M. Husain

      Affiliations

    • Department of Medicine (Neurology), Duke University Medical Center, Durham, NC, United States
    • Neurodiagnostic Center, Department of Veterans Affairs Medical Center, Durham, NC, United States
    • Corresponding Author InformationCorresponding author. Address: Department of Medicine (Neurology), Duke University Medical Center, 202 Bell Building, Box 3678, Durham, NC 27710, United States. Tel.: +1 919 684 8485; fax: +1 919 684 8955.
    • ,
  • Ruzica K. Ristanovic

      Affiliations

    • Sleep Disorders Center, Department of Neurology, ENH-Evanston Hospital, Evanston, IL, United States
    • ,
  • Richard K. Bogan

      Affiliations

    • SleepMed of South Carolina, Columbia, SC, United States

Received 24 November 2007 ,Revised 26 April 2008 ,Accepted 20 May 2008.

References 

  1. Nishino S, Ripley B, Overeem S, Nevsimalova S, Lammers GJ, Vankova J, et al. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol. 2001;50:381–388
  2. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 2000;27:469–474
  3. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA. 1998;95:322–327
  4. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92:573–585
  5. Dahmen N, Bierbrauer J, Kasten M. Increased prevalence of obesity in narcoleptic patients and relatives. Eur Arch Psychiatry Clin Neurosci. 2001;251:85–89
  6. Kok SW, Overeem S, Visscher TL, Lammers GJ, Seidell JC, Pijl H, et al. Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity. Obes Res. 2003;11:1147–1154
  7. Schuld A, Hebebrand J, Geller F, Pollmacher T. Increased body-mass index in patients with narcolepsy. Lancet. 2000;355:1274–1275
  8. Anonymous. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep 2002;25:42–49.
  9. Anonymous. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients. Sleep Med 2005;6:415–421.
  10. Anonymous. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy. J Clin Sleep Med 2005;1:391–397.
  11. Ristanovic RK. Decreased body-mass index (BMI) in narcoleptic patients treated with sodium oxybate. Sleep. 2003;26:A87–A88
  12. Lammers GJ, Pijl H, Iestra J, Langius JA, Buunk G, Meinders AE. Spontaneous food choice in narcolepsy. Sleep. 1996;19:75–76
  13. Bernardis LL, Bellinger LL. The lateral hypothalamic area revisited: ingestive behavior. Neurosci Biobehav Rev. 1996;20:189–287
  14. Steffens AB. Influence of reversible obesity on eating behavior, blood glucose, and insulin in the rat. Am J Physiol. 1975;228:1738–1744
  15. Dube MG, Kalra SP, Kalra PS. Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action. Brain Res. 1999;842:473–477
  16. Beuckmann CT, Yanagisawa M. Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation. J Mol Med. 2002;80:329–342
  17. Crocker A, Espana RA, Papadopoulou M, Saper CB, Faraco J, Sakurai T, et al. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology. 2005;65:1184–1188
  18. Kok SW, Meinders AE, Overeem S, Lammers GJ, Roelfsema F, Frolich M, et al. Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans. J Clin Endocrinol Metab. 2002;87:805–809
  19. Chou TC, Lee CE, Lu J, Elmquist JK, Hara J, Willie JT, et al. Orexin (hypocretin) neurons contain dynorphin. J Neurosci. 2001;21:RC168
  20. Hara J, Yanagisawa M, Sakurai T. Difference in obesity phenotype between orexin-knockout mice and orexin neuron-deficient mice with same genetic background and environmental conditions. Neurosci Lett. 2005;380:239–242
  21. Overeem S, Kok SW, Lammers GJ, Vein AA, Frolich M, Meinders AE, et al. Somatotropic axis in hypocretin-deficient narcoleptic humans: altered circadian distribution of GH-secretory events. Am J Physiol Endocrinol Metab. 2003;284:E641–647
  22. Kok SW, Roelfsema F, Overeem S, Lammers GJ, Frolich M, Meinders AE, et al. Altered setting of the pituitary–thyroid ensemble in hypocretin-deficient narcoleptic men. Am J Physiol Endocrinol Metab. 2005;288:E892–E899
  23. Honda Y, Doi Y, Ninomiya R, Ninomiya C. Increased frequency of non-insulin-dependent diabetes mellitus among narcoleptic patients. Sleep. 1986;9:254–259
  24. Sachs C, Kaijser L. Autonomic control of cardiovascular reflexes in narcolepsy. J Neurol Neurosurg Psychiatry. 1980;43:535–539
  25. Madden TE, Johnson SW. γ-Hydroxybutyrate is a GABAB receptor agonist that increases a potassium conductance in rat ventral tegmental dopamine neurons. J Pharmacol Exp Ther. 1998;287:261–265
  26. Thorpy MJ. Sodium oxybate for the treatment of narcolepsy. Expert Opin Pharmacother. 2005;6:329–335
  27. Dauvilliers Y, Baumann CR, Carlander B, Bischof M, Blatter T, Lecendreux M, et al. CSF hypocretin-1 levels in narcolepsy, Kleine–Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry. 2003;74:1667–1673
  28. Krahn LE, Pankratz VS, Oliver L, Boeve BF, Silber MH. Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1∗0602 status. Sleep. 2002;25:733–736

☆ Disclosure: Drs. Husain and Bogan are on the Speaker’s Bureau for Jazz Pharmaceuticals.

PII: S1389-9457(08)00207-4

doi: 10.1016/j.sleep.2008.05.012

Sleep Medicine
Volume 10, Issue 6 , Pages 661-663 , June 2009

Article Tools